Mechanistic evaluation of VS-6766 (dual RAF/MEK inhibitor) and defactinib (FAK inhibitor) in low-grade serous ovarian cancer models with correlations to clinical response
Stewart, A. R. Pickard, L. Paranjape, E. Perez, V. S. Chowdhury, S. Lustgarten, S. Coma, S. Pachter, J. A. Carey, M. S. DiMattia, G.
Stewart, A. R.
Pickard, L.
Paranjape, E.
Perez, V. S.
Chowdhury, S.
Lustgarten, S.
Coma, S.
Pachter, J. A.
Carey, M. S.
DiMattia, G.
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Stewart AR, Pickard L, Paranjape E, Perez VS, Chowdhury S, Lustgarten S, et al. Mechanistic evaluation of VS-6766 (dual RAF/MEK inhibitor) and defactinib (FAK inhibitor) in low-grade serous ovarian cancer models with correlations to clinical response. Cancer Research. 2022 Jun;82(12). PubMed PMID: WOS:000892509507142.